SIBO

Fibromyalgia and Small Intestinal Bacterial Overgrowth (SIBO)

Fibromyalgia is a condition in which there is pain all over the body, localized to the somatic muscles. This is experienced as soreness over certain points on pressure, in the form of a dull ache which has been present for at least 3 months at the time of diagnosis. The tenderness should be elicited over different points located over all the body quadrants.

What Causes Small Intestinal Bacterial Overgrowth (SIBO)?

What is SIBO?

IBS and SIBO

Small Intestinal Bacterial Overgrowth Diagnosis

Small Intestinal Bacterial Overgrowth (SIBO) Pathophysiology

Small Intestinal Bacterial Overgrowth (SIBO) Signs and Symptoms

Rosacea and Small Intestinal Bacterial Overgrowth (SIBO)

Risk Factors for Small Intestinal Bacterial Overgrowth

Small Intestinal Bacterial Overgrowth (SIBO) Treatment

Fibromyalgia and Gut Health: SIBO and IBS

Latest SIBO News and Research

Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy

Owlstone Medical today announced the close of its Series D financing round.

From Owlstone Medical Ltd 7 Sep 2021

Bedfont Scientific Ltd. teams up with GI Cognition to launch Hydrogen and Methane Breath Testing ‘Home Kits’ to help improve Gastric Health remotely

Bedfont presents its new Hydrogen and Methane Breath Testing Home Kits in association with GI Cognition.

From Bedfont® Scientific Ltd 10 Jun 2021

Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic

Owlstone Medical today announced agreements with Functional Gut Clinic ("FGC") and Functional Gut Diagnostics (“FGD”).

From Owlstone Medical Ltd 18 May 2021

Lab mice may have differences in small-intestine microbiome as compared to humans

There is a growing consensus that the gut microbiome is involved in many aspects of physical and mental health, including the onset of Parkinson's disease, multiple sclerosis, and even some behaviors.

14 Feb 2020

Study finds high rates of small intestinal bacterial overgrowth in patients with restless legs syndrome

Small intestine bacterial overgrowth may be more prevalent among patients with restless legs syndrome (RLS), according to preliminary findings from a small, new study.

10 Jun 2019

Study suggests link between probiotic use and “brain fogginess”

A study conducted at the Medical College of Georgia at Augusta University has shown that probiotic intake can result in a significant build-up of small intestine bacteria that leads to brain fogginess.

8 Aug 2018

Probiotic use could result in disorienting brain fogginess and rapid belly bloating

Probiotic use can result in a significant accumulation of bacteria in the small intestine that can result in disorienting brain fogginess as well as rapid, significant belly bloating, investigators report.

6 Aug 2018

Cedars-Sinai study identifies gut gas associated with diarrhea

Cedars-Sinai investigators have for the first time identified a gas produced in gut that could improve the diagnosis and treatment of patients with two common intestinal illnesses-;small intestine bacterial overgrowth and irritable bowel syndrome.

6 Jun 2018

Bedfont Scientific named as one of top 25 companies on the Future List

Bedfont is a small family business that specialised in the design and manufacture of breath and gas analysis monitors for medical application for over 40 years.

From Bedfont® Scientific Ltd 25 May 2017

Bedfont introduces GastroCH4ECK Gastrolyzer to help detect gastrointestinal disorders

Bedfont Scientific has specialised in the design and manufacture of exhaled breath and gas monitoring instruments since 1976.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfont Scientific’s Gastrolyzer range helps dietitians detect and treat dietary problems

This year Dietitian Week takes place between 6-10 June, marking the 3rd annual awareness week for Dietitians.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfont Scientific’s Gastrolyzer monitors can help detect IBS through simple breath test

April is IBS awareness month and for the IBS Network's 25th Anniversary show, they are highlighting IBS from the patient's perspective.

From Bedfont® Scientific Ltd 5 Dec 2016

Excessive growth of bacteria in small intestine could lead to stunting in young children

Excessive growth of bacteria in the small intestine could be damaging the guts of young children, leading to stunting, scientists from the U.S. and Bangladesh have discovered.

22 Feb 2016

Commonwealth Lab expands access to new IBS test with national agreement with Quest

Commonwealth Laboratories, LLC ("Commonwealth") announced today that it has formed an agreement with Quest Diagnostics ("Quest") that will expand the availability of IBSchek™, a new laboratory developed blood test designed to help physicians quickly and reliably diagnose Irritable Bowel Syndrome (IBS).

From Quest Diagnostics 15 Oct 2015

Overgrowth of bacteria in the gut linked to IBS

An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this "gold standard" method of connecting bacteria to the cause of the disease that affects an estimated 30 million people in the United States.

28 May 2012

Bacteria are key contributors to the cause of IBS, study confirms

25 May 2012

Limited alcohol consumption can cause gastrointestinal problems

Just one drink per day for women -- two for men -- could lead to small intestinal bacterial overgrowth (SIBO) and subsequently cause gastrointestinal symptoms like bloating, gas, abdominal pain, constipation and diarrhea, according to the results of a new study unveiled today at the American College of Gastroenterology's (ACG) 76th Annual Scientific meeting in Washington, DC.

31 Oct 2011

Irritable Bowel Syndrome linked to bacterial overgrowth, food poisoning

Cedars-Sinai researchers have reported two advances in the understanding of Irritable Bowel Syndrome, the most common gastrointestinal disorder in the United States, affecting an estimated 30 million people.

12 May 2011

Study: Antibiotics can provide long-lasting relief to patients with irritable bowel syndrome

A ground-breaking antibiotic therapy developed at Cedars-Sinai Medical Center is the first potential drug treatment to provide irritable bowel syndrome patients with long-lasting relief of their symptoms even after they stop taking the medication, according to a study published in the Jan. 6 issue of the New England Journal of Medicine.

6 Jan 2011

Targeted antibiotics provide safe, long-lasting improvement for IBS patients, says study

A targeted antibiotic provides effective and long-lasting relief of Irritable Bowel Syndrome symptoms, according to the results of two multisite Phase III clinical trials designed by Cedars-Sinai researchers. Rifaximin is the first drug treatment for IBS that relieves symptoms while it's being administered and continues to benefit patients after they stop taking the drug.

5 May 2010

SIBO

Overview

What Causes Small Intestinal Bacterial Overgrowth (SIBO)?

What is SIBO?

IBS and SIBO

Feature Articles

Small Intestinal Bacterial Overgrowth Diagnosis

Small Intestinal Bacterial Overgrowth (SIBO) Pathophysiology

Small Intestinal Bacterial Overgrowth (SIBO) Signs and Symptoms

Rosacea and Small Intestinal Bacterial Overgrowth (SIBO)

Risk Factors for Small Intestinal Bacterial Overgrowth

Small Intestinal Bacterial Overgrowth (SIBO) Treatment

Fibromyalgia and Gut Health: SIBO and IBS

Latest SIBO News and Research

Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy

Bedfont Scientific Ltd. teams up with GI Cognition to launch Hydrogen and Methane Breath Testing ‘Home Kits’ to help improve Gastric Health remotely

Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic

Lab mice may have differences in small-intestine microbiome as compared to humans

Study finds high rates of small intestinal bacterial overgrowth in patients with restless legs syndrome

Study suggests link between probiotic use and “brain fogginess”

Probiotic use could result in disorienting brain fogginess and rapid belly bloating

Cedars-Sinai study identifies gut gas associated with diarrhea

Bedfont Scientific named as one of top 25 companies on the Future List

Bedfont introduces GastroCH4ECK Gastrolyzer to help detect gastrointestinal disorders

Bedfont Scientific’s Gastrolyzer range helps dietitians detect and treat dietary problems

Bedfont Scientific’s Gastrolyzer monitors can help detect IBS through simple breath test

Excessive growth of bacteria in small intestine could lead to stunting in young children

Commonwealth Lab expands access to new IBS test with national agreement with Quest

Overgrowth of bacteria in the gut linked to IBS

Bacteria are key contributors to the cause of IBS, study confirms

Limited alcohol consumption can cause gastrointestinal problems

Irritable Bowel Syndrome linked to bacterial overgrowth, food poisoning

Study: Antibiotics can provide long-lasting relief to patients with irritable bowel syndrome

Targeted antibiotics provide safe, long-lasting improvement for IBS patients, says study

The Increasing Use of Microfluidics in Labs and Hospitals

Designing a new treatment to treat migraine effectively

World Sepsis Month: Increasing Sepsis Awareness, Patient Support, and Improving Survivor Outcomes

SIBO

Overview

Feature Articles

Small Intestinal Bacterial Overgrowth Diagnosis

Small Intestinal Bacterial Overgrowth (SIBO) Pathophysiology

Small Intestinal Bacterial Overgrowth (SIBO) Signs and Symptoms

Rosacea and Small Intestinal Bacterial Overgrowth (SIBO)

Risk Factors for Small Intestinal Bacterial Overgrowth

Small Intestinal Bacterial Overgrowth (SIBO) Treatment

Fibromyalgia and Gut Health: SIBO and IBS

Latest SIBO News and Research

The Increasing Use of Microfluidics in Labs and Hospitals

Designing a new treatment to treat migraine effectively

World Sepsis Month: Increasing Sepsis Awareness, Patient Support, and Improving Survivor Outcomes

Newsletters you may be interested in